Denver, CO – Revelstoke Capital Partners (“Revelstoke”), a Denver-based private equity firm, has completed an investment in Accelecare Wound Centers, Inc. (“Accelecare” or the “Company”). Accelecare, a leading provider of wound care services in the United States, is the first platform acquisition for Revelstoke.
Accelecare provides advanced wound care services in two diversified, highly complementary divisions, Accelecare Wound Centers (“AWC”) and Accelecare Wound Professionals (“AWP”), with significant growth potential, operating synergies, and cross-selling opportunities. AWC is a leading provider of full service wound management solutions to hospitals and related healthcare organizations across the United States. AWP provides wound care specialist physicians to skilled nursing facilities and hospital-based outpatient wound care facilities. Revelstoke will provide Accelecare strategic guidance and additional capital to accelerate its organic growth, pursue selective acquisitions and continue to leverage its scalable business model for continued growth.
“We are excited about the prospects of working with an extremely talented and experienced management team to continue to grow the Company and further solidify its position as a leader in the wound care industry,” noted Mark King, CEO, Managing Partner and Co-Founder of Revelstoke, “We are very pleased to have closed this transaction with a marquee list of institutional equity and lending partners within 56 days of signing an exclusive letter of intent.”
“The resources and expertise that Revelstoke brings to our team allows us to continue our focus on growth while maintaining the quality and efficacy of our services,” said Michael Lester, CEO of Accelecare. Bain Capital Ventures, SV Life Sciences, River Cities Capital Fund and management will continue to own a meaningful portion of the Company.
Revelstoke was represented by Hogan Lovells and Lazard Middle Market LLC. Revelstoke and its eight institutional co-investors invested more than $70 million of equity for a majority interest in Accelecare. Additional debt financing was provided by Ally Commercial Finance, Fifth Third Bank, Siemens Financial Services, Inc., Yukon Partners, The Northwestern Mutual Life Insurance Company and Nationwide Mutual Insurance Company.
Fenwick and West LLP and Cain Brothers & Company represented Accelecare in the transaction.
Based in Bellevue, Washington, Accelecare Wound Centers is a comprehensive wound care and disease management company. Accelecare provides full service wound management solutions to hospitals and related health care organizations across the United States. Accelecare is currently comprised of more than 120 state of the art Advanced Wound Centers staffed with trained physicians, nurses, and specialized technicians that provide efficacious and cost effective wound treatments ensuring positive outcomes. The company’s mission is centered around partnerships with hospitals and skilled nursing facilities, caring services for patients and clinical excellence.
Revelstoke is a private equity firm formed by experienced investors who focus on building exceptional industry-leading companies. Revelstoke strives to partner with management teams to execute on a disciplined organic and acquisition strategy to build industry-leading companies and generate superior investment returns for management owners and investor partners. Revelstoke’s Managing Partners, Mark King, Dale Meyer and Simon Bachleda, have more than six decades of combined private equity investing and capital formation experience having completed more than 100 platform and add-on acquisitions, representing more than $6 billion of total enterprise value.
Mark King, Managing Partner: 303-953-5100
Simon Bachleda, Managing Partner: 303-953-3098
Dale Meyer, Managing Partner: 303-953-3094